Trial intelligence / Profile preview

Immunosuppression in Virus-Negative Inflammatory Cardiomyopathy

2016-003014-28Phase 3Completed

Sponsor
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Start
Jun 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of prednisone, azathioprine in inflammatory cardiomyopathy, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Started Jun 2021; status: completed.

02

Drugs

prednisoneazathioprine
03

Conditions

inflammatory cardiomyopathy

Beyond the preview

Go deeper on 2016-003014-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003014-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call